Themis Medicare Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Themis Medicare Ltd. on BSE

Load latest

Themis Medicare Ltd.

07 Feb 2023

130.81

-5.01%

Company Update

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

This is to inform with reference to our letter dated February 06, 2023, regarding Earning Conference Call, which was scheduled on Wednesday, 8th February, 2023 at 04:30 PM. has been rescheduled to Friday, 10th February, 2023 at 12:30 PM. Details of meeting attached below. Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. No Unpublished Price Sensitive Information (UPSI) will be discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com

pdf

Themis Medicare Ltd.

06 Feb 2023

130.81

-5.01%

Company Update

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

This is to inform with reference to our letter dated January 31, 2023, regarding Earning Conference Call, which was scheduled on Tuesday, 7th February, 2023 at 04:30 PM has been rescheduled to Wednesday, 8th February, 2023 at 04:30 PM. Details of meeting attached below. Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. No Unpublished Price Sensitive Information (UPSI) will be discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com

pdf

Themis Medicare Ltd.

06 Feb 2023

130.81

-5.01%

Company Update

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

In terms of Regulations 47 of SEBI(LODR) Regulations, 2015 the Company has published the Un-Audited Financial Results for the quarter and Nine months ended 31st December,2022 in ''Indian Express'' (English) edition and in Financials Express'' (Gujarati) edition on Saturday, 04th February, 2023. Further, in pursuance of Regulation 30 read with Schedule III (A) (12) please find enclosed the copy of Newspaper articles as published in the above mentioned newspapers. Kindly take the same on record and acknowledge receipt.

pdf

Themis Medicare Ltd.

03 Feb 2023

130.81

-5.01%

Result

THEMIS MEDICARE LTD. - 530199 - Results- Financial Results For December 31, 2023(Quarterly)

BSE India

The Board of Directors at its meeting held today, considered and approved the Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31st December 2022. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter and Nine months ended 31st December, 2022 together with Limited Review Report issued by Krishaan & Co., Chartered Accountants is enclosed herewith. This may be taken as compliance under the Listing Regulations.

pdf

Themis Medicare Ltd.

03 Feb 2023

130.81

-5.01%

Board Meeting

THEMIS MEDICARE LTD. - 530199 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

pdf

Themis Medicare Ltd.

02 Feb 2023

130.81

-5.01%

Corp. Note

THEMIS MEDICARE LTD. - 530199 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received the below mentioned intimation / request for Loss of Share Certificate / issuance of duplicate share certificate from the following shareholder: Folio No Name Certificate No. Distinctive No. No. of Shares 00010747 RAVI KANT 7255 3441401 - 3441500 100 We shall issue the duplicate Share Certificate only after the necessary formalities are carried out by the Shareholder. This may be taken as compliance under the Listing Regulations.

pdf

Themis Medicare Ltd.

31 Jan 2023

130.81

-5.01%

Company Update

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

The Company is scheduling Earning Conference Call on Tuesday, 7th February, 2023 at 04:30 PM. Details of meeting attached below. Note: The schedule of the aforesaid meetings is subject to change. The changes may happen due to exigencies on the part of Fund / Broking House / Company. No Unpublished Price Sensitive Information (UPSI) will be discussed in the meetings/calls. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.themismedicare.com This is for your information and record.

pdf

Themis Medicare Ltd.

27 Jan 2023

130.81

-5.01%

Board Meeting

THEMIS MEDICARE LTD. - 530199 - Board Meeting Intimation for Inter Alia, To Consider, The Un-Audited …

BSE India

THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2023 ,inter alia, to consider and approve With respect to the captioned subject, please be informed that a meeting of the Board of Directors of Themis Medicare Limited is scheduled to be held on Friday 03rd February, 2023 inter alia, to consider, the Un-audited Standalone and Consolidated Financial Results for the Quarter and nine months ended on 31st December, 2022. Further, in continuation of our Letter dated 26th December 2022, the Trading Window in respect of dealing in the Company's Securities was closed for all Directors/Designated Employees from the opening of the trading hours on Sunday, 1st January, 2023, which shall remain closed till the closure of trading hours on 05th February, 2023 (both days inclusive) i.e. till the completion of 48 hours after the declaration of financial results as per the policy for prohibition of Insider Trading ("the Code") adopted by the Company pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time.

pdf

Themis Medicare Ltd.

27 Jan 2023

130.81

-5.01%

Company Update

THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

BSE India

This is to inform that the Company has allotted 2500 (two thousand five hundred only) Equity shares of Rs.10/-(Rupees Ten only) each on January 27, 2023 to those grantees who had exercised their option under the Company's Employee Stock Option Scheme. The said shares will rank pari-passu with the existing shares of the Company in all respect. Please take the above on record and upload this announcement on the website of the Exchange.

pdf

Themis Medicare Ltd.

11 Jan 2023

130.81

-5.01%

Company Update

THEMIS MEDICARE LTD. - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

We are enclosing herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2022 received from Link lntime India Pvt. Ltd., Registrar and Share Transfer Agent of our Company. This is for your information and record.

pdf

Is Themis Medicare Ltd. worth buying?

49 Votes:

Buy 79.59%

Sell 10.2%

Hold 10.2%

58.74% Fall from 52W High

High vol. this week

Themis Medicare Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Themis Medicare Ltd. on BSE